Kowalski A, Schröder R, Martínez F. "Method for the Synthesis of Ethyl 2-(3-(difluoromethyl)-7-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate" [P]. European Patent, EP 3923932 A1, 2017-05-17.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2024, 867, (10), 7088-7116.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2017, 1039, 98-124.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 2-(3-(difluoromethyl)-7-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetate Using HRMS and NMR". Anal. Methods, 2015, 904, (12), 5614-5624.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2014, 1434, 5440-5468.